Entheon Biomedical Corp. announced a non-brokered private placement of 30,000,000 units at a price of CAD 0.1 per unit for gross proceeds of CAD 3,000,000 on April 5, 2022. Each unit consists of one common share of the company and one transferable share purchase warrant, with each warrant exercisable for one additional Share for a period of 36 months from the date of issue at an exercise price of CAD 0.15 per share in year one and CAD 0.25 in years two and three.

All securities to be issued will be subject to a four-month and a day hold period. The Company may pay finder's fees in accordance with the policies of the Canadian Securities Exchange.